Cargando…

Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study

BACKGROUND: Concurrent opioid and stimulant use is on the rise in North America. This increasing trend of use has been observed in the general population, and among people released from prison in British Columbia (BC), who face an elevated risk of overdose post-release. Opioid agonist treatment is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palis, Heather, Zhao, Bin, Young, Pam, Korchinski, Mo, Greiner, Leigh, Nicholls, Tonia, Slaunwhite, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694574/ https://www.ncbi.nlm.nih.gov/pubmed/36434706 http://dx.doi.org/10.1186/s13011-022-00504-z

Ejemplares similares

Association of Mental Health Services Access and Reincarceration Among Adults Released From Prison in British Columbia, Canada
por: Palis, Heather, et al.
Publicado: (2022)

Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration
por: Palis, Heather, et al.
Publicado: (2022)

Peer-led safer supply and opioid agonist treatment medication distribution: a case study from rural British Columbia
por: Scow, Marnie, et al.
Publicado: (2023)

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
por: Palis, Heather, et al.
Publicado: (2021)

Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study
por: Palis, Heather, et al.
Publicado: (2022)

Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia
por: Curtis, Michael, et al.
Publicado: (2023)

Fatal overdoses after release from prison in British Columbia: a retrospective data linkage study
por: Kinner, Stuart A., et al.
Publicado: (2021)

Impact of opioid substitution therapy for Scotland's prisoners on drug‐related deaths soon after prisoner release
por: Bird, Sheila M., et al.
Publicado: (2015)

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment
por: Palis, Heather, et al.
Publicado: (2021)

Engagement of persons with lived experience in research that uses linked administrative health data - the BC Provincial Overdose Cohort.
por: Slaunwhite, Amanda, et al.
Publicado: (2022)

State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain
por: Lyu, Xiru, et al.
Publicado: (2023)

Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study
por: Pearce, Lindsay A, et al.
Publicado: (2020)

Randomized controlled pilot trial of naloxone‐on‐release to prevent post‐prison opioid overdose deaths
por: Parmar, Mahesh K. B., et al.
Publicado: (2016)

The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids
por: Buadze, Anna, et al.
Publicado: (2020)

The Effect of Ethanol on the Release of Opioids from Oral Prolonged-Release Preparations
por: Walden, Malcolm, et al.
Publicado: (2007)

A comparison of opioids and benzodiazepines dispensing in Australia
por: Islam, M. Mofizul, et al.
Publicado: (2019)

Who Are Dispensed the Bulk Amount of Prescription Opioids?
por: Islam, M. Mofizul, et al.
Publicado: (2019)

Trends in Opioid Prescribing and Dispensing by Veterinarians in Pennsylvania
por: Clarke, Dana L., et al.
Publicado: (2019)

Drug use and opioid substitution treatment for prisoners
por: Stöver, Heino, et al.
Publicado: (2010)

Optimising opioid substitution therapy in the prison environment
por: Alam, Farrukh, et al.
Publicado: (2019)

Supporting people leaving prisons during COVID-19: perspectives from peer health mentors
por: McLeod, Katherine E., et al.
Publicado: (2021)

Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach
por: Bunting, Amanda M., et al.
Publicado: (2018)

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis
por: Bodkin, Claire, et al.
Publicado: (2021)

Feasibility and Acceptability of a Digital Health Intervention to Promote Continued Engagement in Medication for Opioid Use Disorder Following Release From Jail/Prison
por: Langdon, Kirsten J, et al.
Publicado: (2022)

Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study
por: Curtis, Michael, et al.
Publicado: (2023)

The impact of the opioid crisis on U.S. state prison systems
por: Scott, Christy K., et al.
Publicado: (2021)

Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007–2016
por: Jones, Wayne, et al.
Publicado: (2020)

Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners
por: Springer, Sandra A., et al.
Publicado: (2012)

Opioid Use Disorder Treatment Decision Making And Care Navigation Upon Release From Prison: A Feasibility Study
por: Banta-Green, Caleb J, et al.
Publicado: (2019)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
por: Sadek, Joseph, et al.
Publicado: (2022)

Prescription opioid dispensing in Canada: an update on recent developments to 2018
por: Jones, Wayne, et al.
Publicado: (2020)

Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
por: Palis, Heather, et al.
Publicado: (2023)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

The authors respond to letters on using prescribed psychostimulants to treat stimulant use disorder
por: Palis, Heather N., et al.
Publicado: (2023)

Opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States, 2007–2015
por: Qato, Danya M., et al.
Publicado: (2021)

Feasibility of Applying the Life History Calendar in a Population of Chronic Opioid Users to Identify Patterns of Drug Use and Addiction Treatment
por: Fikowski, Jill, et al.
Publicado: (2014)

Readiness of Pharmacists Based in Utah About Pain Management and Opioid Dispensing
por: Balough, Meghan M, et al.
Publicado: (2019)

Trends in dispensing of individual prescription opioid formulations, Canada 2005–2020
por: Jones, Wayne, et al.
Publicado: (2022)

Implementation of a Pharmacy Follow-Up Program for Dispensed Opioid Medications
por: Skoy, Elizabeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_udhrief10v7fusrqvq6nmqpdid